We are live on ! Find out more
Sarah Ketterer

Sarah Ketterer Causeway Capital Management

AUM $8.9B Turnover 35.42%
1-Year Est. Return 6.03%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+6.03%
3 Year Est. Return
+72.18%
5 Year Est. Return
+74.16%
10 Year Est. Return
+232.95%
AUM
$8.9B
AUM Growth
-$336M
Cap. Flow
+$158M
Cap. Flow %
1.77%
Top 10 Hldgs %
69.42%
Holding
144
New
22
Increased
20
Reduced
67
Closed
29
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$1.01B
2
AZN icon
AstraZeneca
AZN
+$278M
3
PBR.A icon
Petrobras Class A
PBR.A
+$74.7M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$61M
5
CDW icon
CDW
CDW
+$57.7M

Top Sells

Rank Stock Value
1
CCL icon
Carnival
CCL
+$184M
2
DB icon
Deutsche Bank
DB
+$167M
3
SW icon
Smurfit Westrock
SW
+$104M
4
MRK icon
Merck
MRK
+$80.4M
5
BIIB icon
Biogen
BIIB
+$60.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.39%
2 Healthcare 24.89%
3 Financials 16.79%
4 Industrials 11.25%
5 Technology 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
B icon
126
Barrick Mining
B
$51.4B
– –
-6,966
Closed -$256K –
GSK icon
127
GSK
GSK
$95.7B
– –
-7,163
Closed -$375K –
HTHT icon
128
H World Group
HTHT
$16.1B
– –
-570,437
Closed -$23.8M –
INTR icon
129
Inter&Co
INTR
$1.59B
– –
-100,618
Closed -$546K –
JD icon
130
JD.com
JD
$33.6B
– –
-1,199,207
Closed -$30.6M –
NVS icon
131
Novartis
NVS
$284B
– –
-1,501
Closed -$235K –
ORLA
132
DELISTED
Orla Mining
ORLA
– –
-52,100
Closed -$509K –
OTEX icon
133
Open Text
OTEX
$5.47B
– –
-36,500
Closed -$808K –
PAGS icon
134
PagSeguro Digital
PAGS
$2.01B
– –
-3,130,268
Closed -$28.3M –
PFE icon
135
Pfizer
PFE
$156B
– –
-1,916,801
Closed -$46.2M –
SHG icon
136
Shinhan Financial Group
SHG
$28.9B
– –
-6,594
Closed -$417K –
SLM icon
137
SLM
SLM
$2.9B
– –
-8,774
Closed -$228K –
VEA icon
138
Vanguard FTSE Developed Markets ETF
VEA
$210B
– –
-427,314
Closed -$30.4M –
VEU icon
139
Vanguard FTSE All-World ex-US ETF
VEU
$60.7B
– –
-15,389
Closed -$1.29M –
VICI icon
140
VICI Properties
VICI
$26.6B
– –
-7,985
Closed -$212K –
VIST icon
141
Vista Energy
VIST
$5.47B
– –
-501,275
Closed -$32M –
VWO icon
142
Vanguard FTSE Emerging Markets ETF
VWO
$107B
– –
-35,556
Closed -$2.12M –
WIT icon
143
Wipro
WIT
$20.3B
– –
-448,957
Closed -$1.01M –
JOYY icon
144
JOYY
JOYY
$3.52B
– –
-109,297
Closed -$7.21M –

Similar funds

Sarah Ketterer's Q3 2026 Portfolio in Review

As of Q3 2026, Sarah Ketterer held 144 positions worth $8.9B, down 3.6% from $9.24B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sarah Ketterer's Q3 2026 filing shows 22 new, 20 increased, 67 reduced and 29 closed positions. Its largest new stake was Sea Limited: 9,185,637 shares worth $894M. The largest sale was Carnival, an estimated $184M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Sarah Ketterer's largest Q3 2026 buy was Sea Limited: 9,185,637 shares worth $894M.
  • Sarah Ketterer added most to AstraZeneca in Q3 2026, an estimated $278M increase.
  • Sarah Ketterer's biggest Q3 2026 reduction was Carnival, cutting an estimated $184M.
  • Sarah Ketterer fully exited Biogen in Q3 2026, selling an estimated $60.1M.
  • Sarah Ketterer's ten largest holdings make up 69% of its $8.9B portfolio in Q3 2026.
  • Sarah Ketterer opened 22 new positions and closed 29 in Q3 2026.
  • Sarah Ketterer's portfolio value fell 3.6% quarter-over-quarter to $8.9B.

Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.